Celebrating 15 Years of the WEB™ Device: Transforming Aneurysm Treatment

Terumo Neuro, a forefront leader in neurovascular innovations and a subsidiary of Terumo Corporation, is proud to celebrate the significant milestone of the 15th anniversary of its innovative WEB™ embolization system. Since its launch in October 2010, the WEB device has dramatically changed how wide-neck bifurcation aneurysms are treated, providing a clinically validated, streamlined solution that emphasizes simplicity, safety, and proven effectiveness.

A Paradigm Shift in Aneurysm Treatment

The WEB™ device represents a groundbreaking advancement in the field of neurovascular treatments. Specifically designed to address the challenges posed by aneurysms of the bifurcation with broad necks, this device has shifted the treatment paradigm from traditional methods requiring multiple devices and complex procedures to a more effective and safer single-device approach. Terumo has successfully implanted over 25,000 WEB devices worldwide, underscoring its acceptance and reliability among healthcare professionals.

The origins of this device trace back to its introduction following the Conformité Européenne (CE) mark approval, with the first successful implantation conducted by Professor Joachim Klisch in Germany. Since that day, it has transformed the landscape of aneurysm management, making it easier for healthcare providers to offer this comprehensive therapy to their patients.

Proven Clinical Efficacy

Backed by robust clinical data from seven global Good Clinical Practice (GCP) studies and more than 200 peer-reviewed publications, the WEB device has demonstrated exceptional efficacy and safety over the years. With over 600 patients studied, findings show an impressive track record—1,464 patient years without recorded rebleeding incidents in treated aneurysms. Moreover, long-term follow-up data from major clinical trials (such as WEB-IT and WEBCAST) reaffirm the sustained safety and effectiveness of the device, with morbidity and mortality rates directly related to the device being estimated at 0%.

Increasing Treatment Flexibility

One of the most recent advancements in the WEB product line is the introduction of the WEB 17 system, designed with a lower profile to accommodate smaller aneurysms more efficiently. This addition not only broadens treatment options but also enhances procedural accuracy, enabling healthcare providers to tackle a wider array of aneurysm cases effectively.

Continuous Commitment to Innovation

The consistency in positive clinical outcomes achieved by the WEB device highlights Terumo Neuro’s commitment to innovation and excellence in neurovascular care. As they celebrate this milestone, Terumo Neuro remains dedicated to collaborating with leading physicians worldwide, pushing the boundaries of what is possible in the field of neurovascular treatment.

About Terumo Neuro

Formerly known as MicroVention, Inc., Terumo Neuro was founded in 1997 and acquired by Terumo Corporation in 2006. Dedicated to impactful innovations, their aim is to redefine the landscape of neuroendovascular treatment, significantly enhancing patient outcomes and medical practice standards. Headquartered in Aliso Viejo, California, and with a presence in over 70 countries, Terumo Neuro produces and sells more than thirty products tailored for conditions such as brain aneurysms, ischemic stroke, carotid artery disease, and neurovascular malformations.

About Terumo Corporation

Terumo Corporation (TSE4543), headquartered in Tokyo, Japan, has been a global leader in medical technology for over a century, aiming to contribute to society through healthcare advancements. With a workforce exceeding 30,000 across 160 countries, Terumo offers innovative medical solutions ranging from vascular intervention to essential clinical practice products. With a commitment to enhancing the health of individuals and communities, Terumo continually works to provide value to patients, medical professionals, and global society.

For more information about Terumo Neuro and their revolutionary products, visit Terumo Neuro's Official Website.